McFarlin Barbara L, Balash Jennifer, Kumar Viksit, Bigelow Timothy A, Pombar Xavier, Abramowicz Jacques S, O'Brien William D
Department of Women Children and Family Health Science, University of Illinois at Chicago, Chicago, IL, USA.
Department of Obstetrics and Gynecology, Rush University, Chicago, IL, USA.
Ultrasound Med Biol. 2015 Sep;41(9):2533-9. doi: 10.1016/j.ultrasmedbio.2015.04.022. Epub 2015 May 23.
The objective of this study was to determine whether estimates of ultrasonic attenuation could detect changes in the cervix associated with medically induced cervical remodeling. Thirty-six full-term pregnant women underwent two transvaginal ultrasonic examinations separated in time by 12 h to determine cervical attenuation, cervical length and changes thereof. Ultrasonic attenuation and cervical length data were acquired from a zone (Zonare Medical Systems, Mountain View, CA, USA) ultrasound system using a 5-9 MHz endovaginal probe. Cervical attenuation and cervical length significantly decreased in the 12 h between the pre-cervical ripening time point and 12 h later. The mean cervical attenuation was 1.1 ± 0.4 dB/cm-MHz before cervical ripening agents were used and 0.8 ± 0.4 dB/cm-MHz 12 h later (p < 0.0001). The mean cervical length also decreased from 3.1 ± 0.9 cm before the cervical ripening was administered to 2.0 ± 1.1 cm 12 h later (p < 0.0001). Cervical attenuation and cervical length detected changes in cervical remodeling 12 h after cervical ripening administration.
本研究的目的是确定超声衰减估计值是否能够检测出与药物诱导的宫颈重塑相关的宫颈变化。三十六名足月孕妇接受了两次经阴道超声检查,两次检查时间间隔为12小时,以确定宫颈衰减、宫颈长度及其变化。使用5-9MHz经阴道探头,从Zonare Medical Systems(美国加利福尼亚州山景城)超声系统的一个区域获取超声衰减和宫颈长度数据。在宫颈成熟前的时间点与12小时后的时间点之间,宫颈衰减和宫颈长度显著降低。在使用宫颈成熟剂之前,宫颈平均衰减为1.1±0.4dB/cm-MHz,12小时后为0.8±0.4dB/cm-MHz(p<0.0001)。宫颈平均长度也从给药前的3.1±0.9cm降至12小时后的2.0±1.1cm(p<0.0001)。宫颈衰减和宫颈长度在宫颈成熟给药12小时后检测到宫颈重塑的变化。